Opportunity Information: Apply for RFA DA 24 023

Ending the HIV Epidemic: Focus on Justice Populations with SUD - Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) is a National Institutes of Health (NIH) cooperative agreement opportunity (Funding Opportunity Number RFA-DA-24-023; CFDA 93.279) designed to strengthen HIV prevention and treatment implementation research for people involved with the justice system who also have substance use disorders (SUD). The central idea is to build and support national research capacity that can respond quickly and effectively in geographic areas experiencing spikes in HIV cases, with an emphasis on improving how high-risk individuals are identified and linked to services at the moment they intersect with the justice system (for example, during arrest, booking, incarceration, probation, parole, or re-entry). Because this is structured as a cooperative agreement, awardees should expect substantial programmatic involvement from NIH compared with a typical grant, reflecting a more collaborative model for meeting the initiative's goals.

A major focus of the initiative is the creation of a Data Coordination and Dissemination Center. In practical terms, this kind of center typically serves as the backbone for a network of studies by helping harmonize data collection and measures across projects, supporting data quality and coordination, enabling cross-site analyses, and accelerating the sharing of findings, tools, and implementation lessons. The intent is not only to generate evidence, but to make that evidence usable: identifying who is most at risk for acquiring or transmitting HIV as they come into contact with justice settings, and improving the real-world pathways that connect them to HIV prevention (such as testing, PrEP, harm reduction services) and HIV treatment (such as rapid ART initiation and retention support), alongside prevention and treatment services for substance use disorders (such as medications for opioid use disorder and evidence-based counseling). The opportunity is also marked as "Clinical Trial Optional," meaning applicants may propose work that includes a clinical trial component, but they are not required to do so.

The eligible applicant pool is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); Native American tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses) as well as small businesses; and other organizations. The announcement also explicitly notes additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.

At the same time, there are clear limitations around foreign participation. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, "foreign components" as defined by the NIH Grants Policy Statement are allowed, which generally means a U.S. applicant may include certain scientifically justified elements conducted abroad under NIH rules, even though a foreign institution cannot be the applicant organization.

Key administrative details include that the agency is NIH, the opportunity category is discretionary, and the funding instrument is a cooperative agreement. The original closing date listed is 2023-08-16, and the award ceiling shown is $1,000,000. The listing indicates "ExpectedAwards:" but does not provide a number in the supplied text. The opportunity was created on 2023-04-19. Overall, the program is aimed at producing coordinated, actionable implementation research and data infrastructure that can reduce HIV transmission and improve treatment outcomes among justice-involved people with SUD, especially in hotspots where HIV incidence is rising, by improving identification, linkage, and continuity of HIV and SUD care across justice and community systems.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2023-04-19.
  • Applicants must submit their applications by 2023-08-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 24 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed)

Previous opportunity: BER - Reaching a New Energy Sciences Workforce (BER-RENEW)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 24 023

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 24 023) also looked into and applied for these:

Funding Opportunity
Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA CA 23 029

Funding Number: RFA CA 23 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 24 005

Funding Number: RFA CA 24 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $475,000
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 23 034

Funding Number: RFA CA 23 034
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035

Funding Number: RFA CA 23 035
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed) Apply for RFA CA 23 038

Funding Number: RFA CA 23 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed) Apply for RFA DA 24 019

Funding Number: RFA DA 24 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional) Apply for RFA DA 24 016

Funding Number: RFA DA 24 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) Apply for RFA DA 24 028

Funding Number: RFA DA 24 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) Apply for RFA DA 24 024

Funding Number: RFA DA 24 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required) Apply for RFA DA 24 029

Funding Number: RFA DA 24 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed) Apply for PAR 23 151

Funding Number: PAR 23 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) Apply for PAR 23 183

Funding Number: PAR 23 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $75,000
Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional) Apply for RFA DA 24 018

Funding Number: RFA DA 24 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $295,924
Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 017

Funding Number: RFA DA 24 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $295,924
Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) Apply for PAR 23 182

Funding Number: PAR 23 182
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 024

Funding Number: RFA CA 23 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $800,000
Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) Apply for RFA HG 23 017

Funding Number: RFA HG 23 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) Apply for RFA AG 24 025

Funding Number: RFA AG 24 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional) Apply for RFA AG 24 026

Funding Number: RFA AG 24 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 23 178

Funding Number: PAR 23 178
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 24 023", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: